Sign In
1 Jul 2024 07:02
1 July 2024
Argent BioPharma Ltd.
(Argent BioPharma or the Company)
Company Presentation
Argent BioPharma, an innovative multidisciplinary drug discovery company within the biopharmaceutical sector, announces the publication of its Company Presentation for June 2024 which may be accessed via the following link:
https://www.investi.com.au/api/announcements/rgt/ed231bfb-b84.pdf
-Ends-
Authorised for release by the board of directors, for further information please contact:
Argent BioPharma Roby Zomer CEO & Managing Director +61 8 6555 2950 info@argentbiopharma.com
| Argent BioPharma Rowan Harland Company Secretary +61 8 6555 2950 info@argentbiopharma.com |
UK IR/PR Advisers IFC Advisory Graham Herring / Tim Metcalfe / Zach Cohen +44 203 934 6630 argentbiopharma@investor-focus.co.uk | UK Corporate Broker Shore Capital Toby Gibbs / James Thomas / Lucy Bowden +44 (0)207 408 4090 |
About Argent BioPharma
Argent BioPharma Limited (the "Company") (ASX: RGT; LSE: RGT; ORCQB: RGTLF) is a Clinical-Stage, Revenue Generating Biopharmaceutical Company committed to providing accessible medical treatments for unmet medical needs, to bridge the gap where medical solutions currently fall short. The Group focuses on the Multidisciplinary method with Nanotechnology, developing multi-target therapies for comprehensive disease management, especially concerning to the Central nervous system ("CNS") and Immunology treatments.
Follow us through our social media channels:
LinkedIn: Argent BioPharma
Twitter: @ArgentBioPharma
Facebook: Argent BioPharma
Follow the stocks
